Brenus Pharma Alternatives & Competitors
12 companies similar to Brenus Pharma — Next-generation cancer treatment bringing the immune system one step ahead of ca...
Companies similar to Brenus Pharma
Thunder Biotech
MOTO-CAR®s: Innovative macrophage technology designed to provide effective treatment for p...
Provo, United States
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
Zelluna Immunotherapy
Developing allogeneic TCR-NK therapies for solid tumors
Oslo, Norway
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
Track all Brenus Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Bexion Pharmaceuticals
Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments...
Covington, United States
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
Incyclix Bio
Regaining Cell Cycle Control
Durham, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Alterome Therapeutics, Inc
To Life!
San Diego, United States
Mustang Bio
A fortress biotech Company
Waltham, United States
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
About Brenus Pharma
Brenus Pharma, established in 2019 and headquartered in France, is a cutting-edge clinical-stage biotech firm focused on eradicating cancer recurrence, a significant challenge in solid tumor treatment contributing to 10 million deaths annually. Their innovative platform offers "off-the-shelf" therapeutic solutions, pos...
Development of next-generation in vivo immunotherapies, Creation of off-the-shelf platforms for cancer treatment, Clinical research and trials in immuno-oncology
Cancer patients facing therapeutic failure, Medical professionals specializing in oncology, Healthcare providers involved in cancer treatment
Next-generation Cancer Treatment, Immune System Enhancement, Cancer Recurrence Prevention, Solid Tumors Treatment, Proteomic-driven Immunotherapy, Colorectal Cancer Therapy, Allogeneic Therapeutics, Multiomics Technologies, Immunogenicity Improvement, GMP Manufacturing, Oncology Innovation, Cancer Resistance Prevention, Cell Therapy, Biotech Startup, Cancer Vaccine Development
B2B, B2D
Licensing, Performance Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Brenus Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Brenus Pharma on 17 Sep 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
